Apalutamide Demonstrates Statistically Significant Improvement in Overall Survival in mCSPC

Real-world evidence showed a statistically significant and clinically meaningful improvement in survival with apalutamide over enzalutamide in patients with mCSPC at 24 months.

Authors

Publication Details

Journal
Onco Zine - The International Oncology Network
Published
2024-10-02
DOI
https://doi.org/10.14229/onco.2024.10.06.012
Primary Topic
Prostate Cancer Treatment and Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Apalutamide Demonstrates Statistically Significant Improvement in Overall Survival in mCSPC

Peter Hofland
Onco Zine - The International Oncology Network
Prostate Cancer Treatment and Research
article

Apalutamide Demonstrates Statistically Significant Improvement in Overall Survival in mCSPC

Peter Hofland
article en

Abstract

Real-world evidence showed a statistically significant and clinically meaningful improvement in survival with apalutamide over enzalutamide in patients with mCSPC at 24 months.

Onco Zine - The International Oncology Network
Zero hunger
Openalex Percentile: Top 68%
Prostate Cancer Treatment and Research
DOISourceOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Apalutamide Demonstrates Statistically Significant Improvement in Overall Survival in mCSPC — Peter Hofland · Onco Zine - The International Oncology Network (2024) | TGRS Research Map | TGRS